Exploiting mitochondrial apoptosis for the treatment of cancer

Simone Fulda1

  • 1Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Germany. s.fulda@kinderkrebsstiftung-frankfurt.de

Mitochondrion
|June 4, 2010
PubMed

Insights

Mitochondria regulate cell death and are altered in cancers. Targeting mitochondria offers a promising strategy to eliminate chemotherapy-resistant cancer cells by inducing cell death, independent of upstream signaling disruptions.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Mitochondrial Biology

Background:

  • Mitochondria play a crucial role in regulating cell death pathways.
  • Alterations in mitochondrial function are common in human malignancies.
  • Established cancer therapies often fail due to oncogenic blockade of cell death pathways.

Purpose of the Study:

  • To explore the potential of mitochondria-targeted compounds as an alternative cancer therapy.
  • To investigate how targeting mitochondrial functions can overcome chemotherapy resistance.
  • To enhance understanding of mitochondrial apoptosis mechanisms for novel drug development.

Main Methods:

  • The study focuses on the mechanisms of mitochondrial-mediated cell death.
  • It examines the efficacy of compounds that directly perturb mitochondrial functions.
  • The research explores how these perturbations can overcome resistance to conventional therapies.

Main Results:

  • Mitochondria-targeted drugs can initiate cell death independently of upstream signaling.
  • These agents can overcome drug resistance when conventional therapies fail.
  • Disrupted upstream signaling pathways in cancer cells highlight the need for alternative approaches.

Conclusions:

  • Targeting mitochondria presents a promising strategy for eradicating chemotherapy-resistant cancer cells.
  • A deeper understanding of mitochondrial apoptosis mechanisms is vital for developing new cancer drugs.
  • This knowledge holds potential for future medical applications in cancer treatment.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...